Clinical Trials on Estrogen Receptor Positive in South Africa
Total 645 results
-
City of Hope Medical CenterNational Cancer Institute (NCI); Merck Sharp & Dohme LLCCompletedStage IV Breast Cancer | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Negative | Progesterone Receptor Positive | Triple-Negative Breast CarcinomaUnited States
-
Syndax PharmaceuticalsCompletedBreast Cancer | ER+ Breast Cancer | Estrogen Receptor-Positive Breast Cancer | Breast Cancer, Estrogen Receptor-PositiveUnited States, Czechia, Canada, Hungary, Russian Federation
-
National Cancer Institute (NCI)CompletedRecurrent Breast Carcinoma | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | HER2/Neu Positive | Progesterone Receptor Negative | Progesterone Receptor Positive | Stage IIIC Breast Cancer AJCC v6 | Stage IV Breast Cancer AJCC v6 and v7United States, Puerto Rico
-
Eisai Inc.CompletedBreast Cancer | Estrogen Receptor Positive TumorUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedHER2/Neu Negative | Stage IV Breast Cancer AJCC v6 and v7 | Estrogen Receptor and/or Progesterone Receptor PositiveUnited States
-
Alliance Foundation Trials, LLC.Pfizer; Syneos Health; UNICANCER; German Breast Group; SOLTI Breast Cancer Research... and other collaboratorsActive, not recruitingHER-2 Positive Breast Cancer | Estrogen Receptor Positive Breast CancerUnited States, Spain, France, Italy, Germany, Australia, Portugal, New Zealand
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedEstrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Metastatic Triple-Negative Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Androgen Receptor PositiveUnited States
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast CancerUnited States, Korea, Republic of, China, Poland, Taiwan, Turkey, United Kingdom, Australia, Argentina, Germany, Singapore, Thailand, Israel, Russian Federation, Ukraine, Brazil, South Africa
-
Hoffmann-La RocheRecruitingEstrogen Receptor-Positive, HER2-Negative Advanced Breast CancerBelgium, Korea, Republic of, United States, Canada, China, Italy, France, Brazil, Australia, Argentina, Portugal, Spain, Taiwan, Costa Rica, New Zealand, Poland, Chile, Colombia, Guatemala, Israel, Hungary, India, Thailand
-
Atossa Therapeutics, Inc.InClinRecruitingBreast Neoplasms | Invasive Breast Cancer | HER2-negative Breast Cancer | Estrogen-receptor-positive Breast CancerUnited States
-
Hoffmann-La RocheTerminatedEstrogen Receptor-positive (ER+)/Human Epidermal Growth Factor Receptor (HER2)-Negative Locally Advanced or Metastatic Breast CancerCanada, United States, United Kingdom, Australia, Germany
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast CancerUnited States, Italy, Korea, Republic of, Canada, Germany, United Kingdom, Australia, Belgium, Brazil, China, Denmark, France, Hong Kong, Portugal, Spain, Taiwan, Turkey, Japan, Argentina, Mexico, Israel, Poland, Russian Federation, Peru and more
-
Genentech, Inc.RecruitingEstrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast CancerKorea, Republic of, United States, Spain, Taiwan, United Kingdom, Japan, Germany, Argentina, Turkey, Greece, Italy, Singapore, South Africa
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | Estrogen Receptor Negative | HER2/Neu Negative | Triple-negative Breast Carcinoma | Progesterone Receptor-negativeUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive | Elevated CA15-3 or CEA or CA27-29United States, Puerto Rico, Guam
-
ETOP IBCSG Partners FoundationNational Cancer Institute (NCI); NCIC Clinical Trials Group; Cancer and Leukemia... and other collaboratorsActive, not recruitingRecurrent Breast Carcinoma | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Estrogen Receptor Positive Breast Cancer | Progesterone Receptor Positive TumorUnited States, Canada, Switzerland
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingHER2/Neu Negative | Estrogen Receptor-positive Breast Cancer | Stage IV Breast Cancer AJCC v6 and v7United States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)TerminatedBreast Carcinoma | Estrogen Receptor Negative | Progesterone Receptor NegativeUnited States, Guam
-
National Cancer Institute (NCI)CompletedRecurrent Breast Carcinoma | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive | HER2 Positive Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7United States
-
BeiGeneRecruitingAdvanced Breast Cancer | Metastatic Breast Cancer | Advanced Solid Tumor | Non-small Cell Lung Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Hormone Receptor Positive Breast Carcinoma | HER2-negative Breast Cancer | Hormone Receptor Positive HER-2 Negative Breast Cancer | Hormone-receptor-positive...Australia, United States
-
Johns Hopkins UniversityCompleted
-
University of WashingtonPATH; University of KwaZulu; Umkhuseli Innovation and Research Management (UIRM) and other collaboratorsUnknownTuberculosisSouth Africa
-
Vakzine Projekt Management GmbHUniversity of Stellenbosch; Farmovs-Parexel Bloemfontein, Republic of South... and other collaboratorsCompleted
-
AerasStatens Serum InstitutCompletedTuberculosisSouth Africa
-
International AIDS Vaccine InitiativeBiofabri, S.L; South African Tuberculosis Vaccine Initiative; Universidad de...CompletedTuberculosisSouth Africa
-
Boston Medical CenterBoston University; National Institute of Allergy and Infectious Diseases (NIAID) and other collaboratorsEnrolling by invitationTuberculosis | Illicit Drug UseSouth Africa
-
National Institute of Allergy and Infectious Diseases...Completed
-
Johns Hopkins UniversityUnited States Agency for International Development (USAID)CompletedTuberculosisSouth Africa
-
University of OxfordUniversity of Cape TownCompleted
-
Statens Serum InstitutBill and Melinda Gates Foundation; Aurum Institute; Leiden University Medical... and other collaboratorsRecruiting
-
PATHWorld Health Organization; University of Cape TownCompleted
-
GlaxoSmithKlineCompletedInfections, StreptococcalSouth Africa
-
Boston UniversityNational Institute of Allergy and Infectious Diseases (NIAID); University of... and other collaboratorsCompletedTuberculosis | Drug-resistant TuberculosisSouth Africa
-
Wellcome Trust Liverpool Glasgow Centre for Global...Professor David Lalloo; Professor Hamish Simpson; Professor William J Harrison; Professor Sithombo MaqungoUnknownFracture Healing in HIV-positive PatientsSouth Africa
-
Qurient Co., Ltd.CompletedTreatment-naïve, Sputum Smear-positive Patients With Drug-sensitive Pulmonary TBSouth Africa
-
Vakzine Projekt Management GmbHUniversity of Stellenbosch; Children's Infectious Diseases Clinical Research... and other collaboratorsCompleted
-
Johns Hopkins UniversityUniversity of Witwatersrand, South AfricaCompleted
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingInflammatory Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor NegativeUnited States
-
Mark HatherillMedical Research Council; University of Oxford; Wellcome Trust; Department for... and other collaboratorsCompletedSafety and Immunogenicity of MVA85A Prime and Bacille Calmette-Guerin Boost Vaccination (MVA(TB)029)HIV | TuberculosisSouth Africa
-
AerasSanofi Pasteur, a Sanofi Company; Statens Serum Institut; HIV Vaccine Trials...CompletedTuberculosisSouth Africa
-
Statens Serum InstitutCompleted
-
AerasStatens Serum InstitutCompletedLatent Tuberculosis | Latent Tuberculosis Bacteriology and Histology UnknownSouth Africa
-
Elizabeth Glaser Pediatric AIDS FoundationHarvard School of Public Health (HSPH); Centre for Infectious Disease Research... and other collaboratorsCompletedHIV Infections | Pregnant Women | HIV PositiveSouth Africa, Zambia
-
The Aurum Institute NPCLondon School of Hygiene and Tropical Medicine; Johns Hopkins University; Aurum...CompletedHIV | TuberculosisSouth Africa
-
Massachusetts General HospitalBoston University; University of Cape TownRecruitingHIV Infections | Smoking Cessation | TuberculosisSouth Africa
-
Centers for Disease Control and PreventionJohns Hopkins University; Sanofi; University of Stellenbosch; University of Cape... and other collaboratorsRecruiting
-
National Institute of Allergy and Infectious Diseases...CompletedHIV Infections | TuberculosisSouth Africa
-
Professor Francois VenterUniversity of Cape TownCompletedTuberculosis | HIV-1-infectionSouth Africa
-
University of WashingtonNational Institute of Allergy and Infectious Diseases (NIAID); Human Sciences...RecruitingTuberculosisSouth Africa
-
Biofabri, S.LSouth African Tuberculosis Vaccine Initiative; TuBerculosis Vaccine Initiative and other collaboratorsCompletedTuberculosisSouth Africa